|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash | ||||||
| Deferred transaction costs | ||||||
| Prepaid and other current assets | ||||||
| Total current assets | ||||||
| Non-current assets: | ||||||
| Due from related party, non-current | ||||||
| Property and equipment, net | ||||||
| Total non-current assets | ||||||
| Total assets | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||
| Current liabilities | ||||||
| Accrued expenses | ||||||
| Accounts payable and accrued expenses | ||||||
| Accrued interest, related parties | ||||||
| Due to related parties | ||||||
| Short-term debt, related parties | ||||||
| Related party | ||||||
| Total short-term debt, related parties | ||||||
| Deferred underwriting fee payable | ||||||
| Deferred underwriting fee - common stock payable | ||||||
| Settlement payable | ||||||
| Total current liabilities | ||||||
| Warrant liability | ||||||
| Total liabilities | ||||||
| Stockholders' equity (deficit) | ||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 55,971,633 and 27,064,633 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Stock subscription receivable | ||||||
| Accumulated deficit | ||||||
| Total stockholders' equity (deficit) | ||||||
| Total liabilities and stockholders' equity (deficit) |
Loading...
